93 related articles for article (PubMed ID: 38594879)
1. Emerging role of necroptosis, pyroptosis, and ferroptosis in breast cancer: New dawn for overcoming therapy resistance.
Fu B; Lou Y; Wu P; Lu X; Xu C
Neoplasia; 2024 Jun; 55():101017. PubMed ID: 38878618
[TBL] [Abstract][Full Text] [Related]
2. Targeting regulated cell death (RCD) in hematological malignancies: Recent advances and therapeutic potential.
Zhang Y; Zhou X
Biomed Pharmacother; 2024 Jun; 175():116667. PubMed ID: 38703504
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy for patients with thyroid cancer: a comprehensive appraisal.
Pinheiro Neto A; Lucchesi HL; Valsecchi VADS; Ward LS; Cunha LL
Chin Clin Oncol; 2024 May; ():. PubMed ID: 38859604
[TBL] [Abstract][Full Text] [Related]
4. Regulated cell death in hypoxic-ischaemic encephalopathy: recent development and mechanistic overview.
Wu L; Chang E; Zhao H; Ma D
Cell Death Discov; 2024 Jun; 10(1):277. PubMed ID: 38862503
[TBL] [Abstract][Full Text] [Related]
5. Exploiting cell death and tumor immunity in cancer therapy: challenges and future directions.
Lu J; He R; Liu Y; Zhang J; Xu H; Zhang T; Chen L; Yang G; Zhang J; Liu J; Chi H
Front Cell Dev Biol; 2024; 12():1416115. PubMed ID: 38887519
[TBL] [Abstract][Full Text] [Related]
6. Regulated vascular smooth muscle cell death in vascular diseases.
Yin Z; Zhang J; Shen Z; Qin JJ; Wan J; Wang M
Cell Prolif; 2024 Jun; ():e13688. PubMed ID: 38873710
[TBL] [Abstract][Full Text] [Related]
7. Non-lethal outcomes of engaging regulated cell death pathways in cancer.
Kalkavan H; Rühl S; Shaw JJP; Green DR
Nat Cancer; 2023 Jun; 4(6):795-806. PubMed ID: 37277528
[TBL] [Abstract][Full Text] [Related]
8. Targeting novel regulated cell death: Ferroptosis, pyroptosis and necroptosis in anti-PD-1/PD-L1 cancer immunotherapy.
Yu L; Huang K; Liao Y; Wang L; Sethi G; Ma Z
Cell Prolif; 2024 Apr; ():e13644. PubMed ID: 38594879
[TBL] [Abstract][Full Text] [Related]
9. Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy.
Gao W; Wang X; Zhou Y; Wang X; Yu Y
Signal Transduct Target Ther; 2022 Jun; 7(1):196. PubMed ID: 35725836
[TBL] [Abstract][Full Text] [Related]
10. Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research.
Tong X; Tang R; Xiao M; Xu J; Wang W; Zhang B; Liu J; Yu X; Shi S
J Hematol Oncol; 2022 Dec; 15(1):174. PubMed ID: 36482419
[TBL] [Abstract][Full Text] [Related]
11. Non-apoptotic regulated cell death mediates reprogramming of the tumour immune microenvironment by macrophages.
Sun C; Zhan J; Li Y; Zhou C; Huang S; Zhu X; Huang K
J Cell Mol Med; 2024 Apr; 28(8):e18348. PubMed ID: 38652105
[TBL] [Abstract][Full Text] [Related]
12. Ferroptosis, necroptosis, and pyroptosis in anticancer immunity.
Tang R; Xu J; Zhang B; Liu J; Liang C; Hua J; Meng Q; Yu X; Shi S
J Hematol Oncol; 2020 Aug; 13(1):110. PubMed ID: 32778143
[TBL] [Abstract][Full Text] [Related]
13. Inflammation-related pyroptosis, a novel programmed cell death pathway, and its crosstalk with immune therapy in cancer treatment.
Hsu SK; Li CY; Lin IL; Syue WJ; Chen YF; Cheng KC; Teng YN; Lin YH; Yen CH; Chiu CC
Theranostics; 2021; 11(18):8813-8835. PubMed ID: 34522213
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
